The role of Angiotensin II as a pro-fibrotic mediator has been established in models of cardiac, hepatic and renal fibrosis. The administration of Angiotensin-Converting Enzyme (ACE) – inhibitors to these models results in a reduction in the myofibroblast population and collagen synthesis. In rodent excisionat wound-healing experiments, an ACE inhibitor reduced the rate of wound contraction, collagen deposition and angiogenesis. Using immunohistochemistry, the presence of Angiotensin I receptors was identified within tissue samples from patients with Dupuytren's disease. These were found to be co-localised with areas of myofibrobtast expression. This co-localisation has implications for the potential of pharmacological regulation of Dupuytren's disease. Further research is necessary to confirm whether the use of ACE-inhibitors can modulate this disease process, which until now has not been responsive to safe, effective pharmacological treatment.
Get full access to this article
View all access options for this article.
References
1.
MoraPD, and McCullochCA (1994): Dependence of collagen remodelling on alpha-smooth muscle actin expression by fibroblasts, J Cell Physiol, 159, 161–75.
2.
AzzaroneB, Failly-CrepinC, Daya-GrosjeanL, ChaponnierC., and GabbianiG (1983): Abnormal behavior of cultured fibroblasts from nodule and nonaffected aponeurosis of Dupuytren's disease, J Cell Physiot, 117, 353–61.
3.
De Carvalho FrimmC, SunY, and WeberKT (1997): Angiotensin II receptor blockade and myocardial fibrosis of the infarcted rat heart, J Lab Clin Med, 129, 439–46.
4.
DesmouliereA, and GabbianiG (1996): The role of the myofibroblast in wound heaqling and fibrocontractive diseases, Plenum Press, New York.
5.
DostalDE, RothblumKN, CherninMI, CooperGR, and BakerKM (1992): Intracardiac detection of Angiotensinogen and renin: a Localized renin-Angiotensin system in neonatal rat heart, Am J Physiol, 263, C838–50.
6.
FaouziS, Le BaitB, HeaudV, BoussarieL, SaricJ, Bioulac-SageP, BalabaudC, and RosenbaumJ (1999): Myofibroblasts are responsible For collagen synthesis in the stroma of human hepatocellular carcinoma: an in vivo and in vitro study, J Hepatol, 30, 275–84.
7.
FooIT, NaylorIL, TimmonsMJ, and TrejdosiewiczLK (1992): Intracellular actin as a marker for myofibroblasts in vitro, Lab Invest, 67, 727–33.
8.
GabbianiG (1992): The biology of the myofibroblast, Kidney Int, 41, 530–2.
9.
GabbianiG, HirschelB, RyanG, StatkevP, and MajnaG (1972): Granulation tissue as a contractile organ. A study of structure and function., Journal of Experimental Medicine., 135. 719–34.
10.
GarnerW, RittenbergT, ErlichP, KarimolS, RodriguezJL, SmithDJ, and PhanSH (1995): Hypertrophie scar fibroblasts accelerate collagen gel contraction, Wound Repair and Regeneration, 3, 185–191.
11.
GochtA, BosmullerHC, BasalerR, TavassoliFA, MoinfarF, KatenkampD, SchirrmacherK, LudersP, and SaegerW (1999): Breast tumors with myofihrobtastic differentiation: clinico-pathological observations in myofihroblastoma and myofihrosarcoma, Farhat Res Pract, 195, 1–10.
12.
GrinnellF, ZhuM, CarlsonMA, and AbramsJM (1999): Release of mechanical tension triggers apoptosis of human fibroblasts in a model of regressing granulation tissue, Exp Cell Res, 248, 608–19.
HsuehWA, DoYS, AndersonPW, and LawRE (1995): Angiotensin II in cell growth and matrix production, Adv Exp Med Biot, 377, 217–23.
15.
JohnstonCI (1990): Biochemistry and pharmacology of the renin-Angiotensin system, Drugs, 39 Suppl 1, 21–31.
16.
KanetoH, MorrisseyJ, McCrackenR, ReyesA, and KlahrS (1994): Enalapril reduces collagen type IV synthesis and expansion of the interstitiurn in the obstructed rat kidney, Kidney tot, 45, 1637–47.
KatwaLC, SunY, CampbellSE, TyagiSC, DhallaAK, KandataJC, and WeberKT (1998): Pouch tissue and Angiotensin peptide generation, J Mal Cell Cordial, 30, 1401–13.
19.
KeeleyFW, ElmosethiA, and LeenenFH (1992): Enalapril suppresses normal accumulation of elastin and collagen in cardiovascular tissues of growing rats, Am J Physiol,262, H1013–21.
20.
KimuraB, SumnersC, and PhillipsMI (1992): Changes in skin Angiotensin II receptors in rats during wound healing, Biochem Biophys Res Commun, 187, 1083–90.
21.
KlahrS, and MorrisseyJJ (1997): Comparative study of ACE inhibitors and Angiotensin II receptor antagonists in interstitial scarring, Kidney Int Suppl, 63, 5111–4.
22.
LeeAA, DillmannWH, McCullochAD, and VillarrealFJ (1995): Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac Fibroblasts, J Mal Cell Cordial, 27, 2347–57.
23.
MakinoN, HataT, SuganoM, NeonIM, and YanagaT (1996): Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of Angiotensin type 1 receptor in rats, J Mol Cell Cordial, 28, 507–17.
24.
McGrathMH, and EmeryJMd (1985): The effect of inhibition of angiogenesis in granulation tissue on wound healing and the fibroblast, Ann Plast Surg15, 135–22.
25.
McKirdyS, TzafettaK, NaylorI, and SharpeDT (2000a): The effect of ace inhibitor lisinopril on the heating of excisional wounds in the rat., Wound Repair Regeneration, 8, supplement 405.
26.
McKirdyS, TzefettaK., NaylorI, and SharpeD (2000b): The effect of lisinopril on the healing of excisional skin wounds of the rat., British Journal of Pharmacology, 131, supplement 22P.
27.
MaunaS, HorikawaY, OkamotoM, and KurosawaT (1998): Preventive effect of ACE inhibitor on interstitial myofibroblast Formation and matrix deposition in a nephritic model. Ren Fail, 20, 481–91.
28.
MoulinV, AngerFA, GarretD, and GermainL (2000): Role of wound heating myofibroblasts on re-epithelialization of human skin, Burns, 26. 3–12.
29.
MoulinV, CastitlouxG, AugerFA, GarretD, O'Connor-McCourtMD, and GermainL (1998): Modulated response to Cytokines of human wound healing myofibroblasts compared to dermal fibroblasts, Exp Cell Res, 238, 283–93.
30.
MoulinV, GarretD, AugerFA, O'Connor-McCourtM, Castii[ouxG, and GermainL (1999): What's new in human wound-healing myofibroblasts?, Corr Top Pathet, 93, 123–33.
31.
NaylorI, ColemanD, ColemanR, CrossS, and FooITH (1994): In Dupuytren's Disease: Pathobiochemistry and Clinical Management.Springer-Verlag, Germany, pp. 139–150.
32.
NguyenL, WardW F, Ts'aoCH, and MoltenA (1994): Captopril inhibits proliferation of human lung fibroblasts in culture: a potential anlifibrotic mechanism, Proc Soc Exp Biot Med, 205, 80–4.
33.
NunohiroT, AshizawaN, GrafK, HsuehWA, and YanaK (1999): Angiotensin II promotes integrin-mediated collagen gel contraction by adult rat cardiac fibroblasts, Jpn Heart J, 40, 461–9.
34.
OuR, SunY, GanjamVK, and WeberKT (1996): In situ production of Angiotensin II by fibrosed rat pericardium, J Mol Celt Cordial, 28, 1319–27.
35.
PhillipsM I, KimuraB, KrimA J, KonicekJR, and FossGT (1991): Angiotensin II (AngII) in skin may act as a growth factor and enhance wound healing, FASEB J, 1991, A904.
36.
PittetB, Rubbia-BrandtL, DesmouliereA, SappinoA, RoggeroP, GuerretSG, GrimaudJA, LacherR, MontandonD, and GabbianiG (1994a): Effect of gamma-interferon on the clinical and biologic evolution of hypertrophic scars and Dupuytren's disease: an open pitot study., Plastic & Reconstructive Surgery., 93. 1224–35.
37.
PowellDW, MifflinRC, ValentichJD, CroweSE, SaadaJI, and WestAB (1999): Myofibroblasts. II Intestinal subepithelial myofibroblasts, Am J Physiol, 277, C183–201.
38.
Ra miresFJA, SunY, and WeberKT (1998): Myocardial fibrosis associated with aldosterone or Angiotensin II administration: attenuation by calcium channel blockade, J Mol Celt Cordial, 30, 475–83.
39.
RamosSG, MontenegroAP, GoissisG, and RossiMA (1994): Captopril reduces collagen and mast cell and eosinophil accumulation in pig serum-induced rat liver fibrosis, Pothat Int, 44. 655–61.
40.
RayanGM, and TomasekJJ (1994): Generation of contractile force by cultured Dupuytren's disease and normal palmar fibroblasts. Tissue Cell, 26, 747–56.
41.
RodgersK, AbikoM, GirgisW, DizeregaG., St. AmandK, and CampeauJ (1997): Acceleration of dermal tissue repair by Angiotensin II, Wound Repair and Regeneration, 5, 175–183.
42.
RyanG, CliffW, GabbianiG, IrleC, MontandonO, StatkovP, and MajnoG (1974): Myofibroblasts in human granulation tissue., Human Pathology., 5, 55–67.
43.
Schmitt-GraffA, DesmouliereA, and GabbianiG (1994): Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity, Virchows Arch, 425, 3–24.
44.
SchorbW, SoonGW, DostalDE, ConradKM, ChangKC, and BakerKM (1993): Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts, Circ Res, 72, 1245–54.
45.
SunY, Diaz-AriasAA, and WeberKT (1994): Angiotensin-converting enzyme, bradykinin, and Angiotensin II receptor binding in rat skin, tendon, and heart valves: an in vitro, quantitative autoradiographie study, J Lob Clin Med, 123, 372–7.
46.
SunY, RemiresFJ, ZhouG, GanjamVK, and WeberKT (1997): Fibrous tissue and Angiotensin II, J Mol Celt Cordial, 29, 2001–12.
47.
SunY, RatajskaA, and WeherKT (1995): Inhibition of Angiotensin-converting enzyme and attenuation of myocardial fibrosis by lisinopril in rats receiving Angiotensin II, J Lab Clin Med, 126, 95–101.
48.
SunY, and WeberKT (1996a): Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart, J Mai Call Cordial, 28, 851–8.
49.
SunY, and WeberKT (1996b): Cells expressing Angiotensin II receptors in fibrous tissue of rat heart. Cardiovasc Res, 31, 518–25.
50.
SunY, ThangJQ, ZhangJ, and RamuresFJ (1998): Angiotensin II, transforming growth factor-betaI and repair in the infarctedheart, J Mol Cell Cordial, 30, 1559–69.
51.
TomasekJJ, VaughanMB, and HaaksmaCJ (1999): Cellular structure and biology of Dupuytren's disease, Hand Clin, 15, 21–34.
52.
van KestevenCA, van HeugtenHA, LamersJM, SaxenaPR, SchalekampMA, and DanserAH (1997): Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts, J Mol Cell Cordial, 29, 2147.57.
53.
VillarrealFJ, KimNN, UngabGD, PrintsMP, and OillmannWH (1993): Identification of functional Angiotensin II receptors on rat cardiac fibroblasts, Circulation, 88, 2849–61.
54.
ViswanathanM, and SaavedraJM (1992): Expression of Angiotensin II AT2 receptors in the rat skin during experimental wound healing, Peptides, 33, 783–6.
55.
WalshDA, HuDE, WhartonJ, CatravasJD, BlakeDR, and FanTP (1997): Sequential development of Angiotensin receptors and Angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma, Br J Pharmacol, 120, 1302–11.
56.
WardleEN (1999): Modulatory proteins and processes in alliance with immune cells, mediators, and extracellular proteins in renal interstitial fibrosis, Ren Foil, 21, 121–33.
57.
WeberKT, SunY, and KatwaLC (1996): Wound healing following myocardial infarction, Clin Cardiol, 19, 447–55.
58.
WeberKT, SunY, and KatwaLC (1997a): Myofibroblasts and local Angiotensin II in rat cardiac tissue repair, Int. J Biochem Cell Biol, 29, 31–42.
59.
WeberKT, SunY, KatwaLC, and CleutjensJP (1997b): Tissue repair and Angiotensin II generated at sites of healing, Basic Res Cordial, 92, 75–8.
60.
WeberKT, SwamynathanSK, GuntakaRV, and SunY (1999): Angiotensin II and extracellular matrix homeostasis, Int J Biochem Cell Biot, 31, 395–403.
61.
WilsonDP, SawardL, ZahradkaP, and CheungPK (1999): Angiotensin II receptor antagonists prevent neointimal proliferation in a porcine coronary artery organ culture model, Cardiovasc Res, 42, 761–72.
62.
WuLL, YangN, RoeCJ, CooperME, GilbertRE, AtkinsRC, and LanHY (1997): Macrophage and myofibroblast proliferation in remnant kidney: role of Angiotensin II, Kidney Int Suppl, 63, S221–5.
63.
YamateJ, OkadoA, KuwamuraM, TsukamotoY, OhashiF., KisoY, NakatsujiS, KotaniT, SakumaS, and LamarreJ (1998): Immunohistochemical analysis of macrophages. myofibroblasts, and transforming growth factor-beta localization during rat renal interstitial fibrosis following long-term unilateral ureteral obstruction, Toxicol Pathol.26, 793–801.
64.
YokozekiM, BabaY, ShimokawaH, KoriyamaK, and KurodaT (1999): Interferon-gamma inhibits the myofibroblastic phenotype of rat palatal fibroblasts induced by transforming growth factor-betal in vitro, FEBS Lett, 442, 61–4.
65.
YuW, NaimJO, and LanzafameRJ (1994): Expression of growth factors in early wound healing in rat skin, Losers Surg Med, 15, 281–9.
66.
ZhangJ, SunY, ThangJQ, RamiresFJ, and WeberKT (1999): Appearance and regression of rat pouch tissue. J Mol Cell Cardiol, 31, 1005–13.
67.
ZhouG, KandalaJC, TyagiSC, KatwaLC, and WeberKT (1996): Effects of Angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts. Mol Cell Biochem, 154, 171–8.
